Academic Programme

Graduate Programme OHNU - Oncology, Hematology and Nuclear Medicine - Master's degree

Diplôme national de master contrôlé par l'État

Résumé

Objectives: To train students in oncology & hematology in basic research, applied diagnostic research, therapeautics or clinical research Read more

Accéder aux sections de la fiche

Details

General information

- Entry: September 2024 (Master 1 or Master 2)
- Duration: 1 or 2 years
- Place: Nantes
- Langue: English and French
 

Laboratory

Introduction

The Oncology, Hematology and NUclear Medicine Graduate Programme is established in Nantes. It is accessible to students at master's and doctoral levels.
The programme combines three disciplines to meet the challenge of understanding, detecting and treating cancers. This requires a multi-scale (from a single cell to the whole body) and interdisciplinary approach (oncology, immunology, targeted therapies, bioinformatics analysis). Moreover, it addresses all aspects of tumour ecosystem development in different types of cancers (solid and hematological malignancies) and the specific problems of medical imaging that stimulating and mapping tumours non-invasively - a multi-scale cellular approach of multimodal full body imaging (PET-MRI, innovative radiopharmaceuticals...)
The GP approaches therapeutic challenges, including innovative therapies such as targeted therapies, immunotherapies and therapeutic nuclear medicine and theranostic approaches in multiple solid and hematological tumours.
 

Why joining the Oncology, Hematology and Nuclear Medicine Graduate Programme (OHNU)?

Our Graduate Programmes are trainings by and through elemental and translational research.
GP OHNU scientific areas:

  • Immunomodulation of the tumour microenvironment and immunotherapy of cancers
  • Nuclear oncology
  • Signalling in oncogenesis, angiogenesis and permeability
  • Adaptation to stress and tumour escape
  • Integrated cancer genomics
  • Chromatin and transcriptional deregulation in paediatric bone sarcoma
  • Plasticity of the tumour ecosystem after radiotherapy
  • Molecular vulnerabilities of tumour escape in mature Bcell malignancies
  • Lymphocyte manipulation for immunotherapy

Admission

Entry requirement

Academic requirement

  • Bachelor’s degree in Life Sciences

Language requirement:

Students must have the ability to read and do research in English

Application

Application procedure

Selection: file review

Application procedure for the 2023-2024 academic year

For students who do not live in France and do not have French nationality:

  • Countries that are part of the Campus France procedure, please note that the inscription will be opened from 1st October to 31st December of the year before the entry year. (Ex: Inscription period from 01/10/2023 to 31/01/2024 for the entry date on 01/09/2024). For more information please access to these links: www.campusfrance.org or Nantes Université – CEF procedure
  • Countries that do not use the Campus France procedure (including EU countries), please follow our VAEE procedure.

For students who have French nationality or resident in France, please follow Candidature en Master

Programme

First year of Master

What's next?

Level of education obtained after completion

Bac+5

Competencies acquired

  • Conduct research and analyse bibliographic and technological resources
  • Design a Biology-Health project in one's field of specialisation
  • Develop an experiment in Biology-Health
  • Analyse data collected in a fundamental, clinical or pharmacological research study
  • Value one's results and scientific production

Career opportunities

Further studies

After two years of the Master's programme, you will have the choice of developing your own career or pursuing a research project at the doctoral level.

Mis à jour le 29 February 2024.